DAWNRAYS
LIVE

Serial Number

79084679

Owner

Suzhou Dawnrays Pharmaceutical Co., Ltd.

Filing Date

Apr 27, 2010

Add to watchlist:

No watchlists yet
View on USPTO

DAWNRAYS Trademark

Serial Number: 79084679 • Registration: 4219862

DAWNRAYS is a trademark filed by Suzhou Dawnrays Pharmaceutical Co., Ltd. on April 27, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Suzhou Dawnrays Pharmaceutical Co., Ltd. (2 trademarks)

22 Tianling Road

Entity Type: 03

Trademark Details

Filing Date

April 27, 2010

Registration Date

October 9, 2012

Published for Opposition

July 24, 2012

Cancellation Date

April 27, 2020

Goods & Services

Chemical preparations for pharmaceutical purposes for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Pharmaceutical preparations for injection for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Pharmaceutical preparations in tablet form for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Chemical preparations for medical purposes for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Prepared traditional Chinese medicines, namely, medicinal herb extracts and herb teas in preserved form for the treatment of respiratory system diseases, digestive system diseases, liver diseases, cardio-vascular system diseases and nervous system diseases; Medicines for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases in humans; Medicines in capsule form for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
May 16, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
May 16, 2021 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Feb 28, 2020 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jan 31, 2020 INTS
INVALIDATION PROCESSED
Jan 31, 2020 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 10, 2020 INTR
CANCELLED SECTION 71
May 10, 2019 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 19, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 28, 2013 FICS
FINAL DISPOSITION PROCESSED
Jan 28, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 9, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 9, 2012 R.PR
NOTIFICATION PROCESSED BY IB
Sep 22, 2012 GPNX
PUBLISHED FOR OPPOSITION
Jul 24, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 4, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 4, 2012 OP2R
NOTICE OF PUBLICATION
Jul 4, 2012 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 18, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 17, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2012 TROA
NON-FINAL ACTION MAILED
Feb 27, 2012 CNRT
NON-FINAL ACTION WRITTEN
Feb 24, 2012 CNRT
NOTIFICATION PROCESSED BY IB
Feb 11, 2012 GPNX
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2012 TROA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 11, 2012 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 11, 2012 OPNR
NON-FINAL ACTION MAILED
Oct 11, 2011 CNRT
NON-FINAL ACTION WRITTEN
Oct 7, 2011 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 6, 2011 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 3, 2011 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 22, 2011 PREV
ASSIGNED TO LIE
Sep 16, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 1, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 10, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2011 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 10, 2011 ERFR
FINAL REFUSAL MAILED
Feb 22, 2011 CNFR
FINAL REFUSAL WRITTEN
Feb 21, 2011 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2011 TROA
REFUSAL PROCESSED BY IB
Sep 4, 2010 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 10, 2010 RFCS
REFUSAL PROCESSED BY MPU
Aug 10, 2010 RFRR
APPLICATION FILING RECEIPT MAILED
Aug 10, 2010 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 9, 2010 RFCR
NON-FINAL ACTION WRITTEN
Aug 8, 2010 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 5, 2010 REPR